Table 2.

Summary of pharmacological activities of p-hydroxybenzoic acid.

References	Study Type	Experimental Model	Pharmacological Potential	Study Outcomes
32	in vivo	Wistar normal rats	Anti-hyperglycemic	↓plasma glucose, ↑serum insulin, ↑liver glycogen
33	in vivo	Wistar STZ-diabetic rats	Anti-hyperglycemic	↓plasma glucose
34	in vitro	Food pathogenic bacteria, plant pathogenic bacteria, yeasts and plant pathogenic fungi	Anti-microbial	↑antimicrobial activity against S. aureus, L. mesenteroides, S. cerevisiae and C. albicans

Abbreviation: C. albicans, Candida albicans; L. mesenteroides, Leuconostoc mesenteroides; S. aureus, Staphylococcus aureus; S. cerevisiae, Saccharomyces cerevisiae; STZ-diabetic, streptozotocin-diabetic